Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.

Mol Cancer · 2008 · PMC2613402 · PMID 18990230

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

a weak trendP = 0.071so close (0.05 < p ≤ 0.1)

In univariate survival analysis using log-rank test, loss of SFRP2 protein expression was not associated with DFS ( P = 0.237), but a weak trend was detected towards reduced OS ( P = 0.071) (Figure 6 ).

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.